Publication

Lentivirally Delivered Glial Cell Line-Derived Neurotrophic Factor Increases the Number of Striatal Dopaminergic Neurons in Primate Models of Nigrostriatal Degeneration

Downloadable Content

Persistent URL
Last modified
  • 05/21/2025
Type of Material
Authors
    Stephane Palfi, Rush University Medical CenterLiza Leventhal, Rush University Medical CenterYaping Chu, Rush University Medical CenterShuang Y. Ma, Rush University Medical CenterMarina Emborg, Rush University Medical CenterRoy Bakay, Emory UniversityNicole Déglon, Université de LausannePhilippe Hantraye, Service Hospitalier Frédéric JoliotPatrick Aebischer, Université de LausanneJeffrey H. Kordower, Rush University Medical Center
Language
  • English
Date
  • 2002-06-15
Publisher
  • Lippincott, Williams & Wilkins
Publication Version
Copyright Statement
  • Copyright © 2002 Society for Neuroscience
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0888-0395
Volume
  • 22
Issue
  • 12
Start Page
  • 4942
End Page
  • 4954
Grant/Funding Information
  • This work was supported by a grant from the Department of Defense; a grant from the Parkinson's Foundation of the National Capital Area; and the Charles and M. V. Shapiro Foundation
Abstract
  • The primate striatum contains tyrosine hydroxylase (TH)-immunoreactive (ir) neurons, the numbers of which are augmented after dopamine depletion. Glial cell line-derived neurotrophic factor (GDNF) strongly modulates the viability and phenotypic expression of dopamine ventral mesencephalic neurons. The effect of GDNF on TH-ir neurons intrinsic to the striatum has yet to be investigated. In the present study, stereological counts of TH-ir striatal neurons in aged and parkinsonian nonhuman primates revealed that GDNF delivered via a lentiviral vector (lenti-) further increased the number of these cells. Aged monkeys treated with lenti-GDNF displayed an eightfold increase in TH-ir neurons relative to lenti-β-galactosidase-treated monkeys. Unilateral 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment alone in young monkeys resulted in a bilateral eightfold increase in TH-ir striatal cells. This effect was further magnified sevenfold on the side of lenti-GDNF treatment. These cells colocalized with the neuronal marker neuronal-specific nuclear protein. Some of these cells colocalized with GDNF-ir, indicating that an alteration in phenotype may occur by the direct actions of this trophic factor. Thus, GDNF may mediate plasticity in the dopamine-depleted primate brain, which may serve to compensate for cell loss by converting striatal neurons to a dopaminergic phenotype.
Author Notes
  • Dr. Jeffrey H. Kordower, Department of Neurological Sciences, Rush Presbyterian Medical Center, 2242 West Harrison Street, Chicago, IL 60612. E-mail: jkordowe@rush.edu
Keywords
Research Categories
  • Health Sciences, Medicine and Surgery
  • Biology, Neuroscience

Tools

Relations

In Collection:

Items